Soluble Urokinase Receptor and Chronic Kidney Disease

2015411 citationsJournal Articlebronze Open Access

Authors

Salim S. Hayek · Emory University

Sanja Sever · Harvard University

Yi-An Ko · Cardiovascular Institute Hospital

Howard Trachtman · NYU Langone Health

Mosaab Awad · Emory University

Shikha Wadhwani · Rush University Medical Center

Mehmet M. Altintas ·

Abstract

An elevated level of suPAR was independently associated with incident chronic kidney disease and an accelerated decline in the eGFR in the groups studied. (Funded by the Abraham J. and Phyllis Katz Foundation and others.).

Topics & Keywords

Renal Diseases and Glomerulopathies Protease and Inhibitor Mechanisms Chronic Kidney Disease and Diabetes

UN Sustainable Development Goals

No poverty

Publication Details

Published in: New England Journal of Medicine

Volume 373, Issue 20, pp. 1916-1925

DOI: 10.1056/nejmoa1506362

Field-Weighted Citation Impact: 24.14